This product is for research use only, not for human use. We do not sell to patients.
Size | Price | Stock |
---|---|---|
250mg | $1020 | Check With Us |
500mg | $1590 | Check With Us |
1g | $2385 | Check With Us |
Cat #: V0465 CAS #: 865362-74-9 Purity ≥ 98%
Description: FR-180204 (FR180204) is a novel, potent, selective and ATP-competitive inhibitor of ERK (extracellular signal-regulated kinase) with potential anti-inflammatory activity and has the potential to be used as a new therapy for rheumatoid arthritis.
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
Molecular Weight (MW) | 327.34 |
---|---|
Molecular Formula | C18H13N7 |
CAS No. | 865362-74-9 |
Storage | -20℃ for 3 years in powder formr |
-80℃ for 2 years in solvent | |
Solubility In Vitro | DMSO: 65 mg/mL (198.6 mM)r |
Water: <1 mg/mLr | |
Ethanol: 2 mg/mL warmed (6.1 mM) | |
SMILES Code | NC1=NNC2=NN=C(C3=C4C=CC=CN4N=C3C5=CC=CC=C5)C=C21 |
Synonyms | FR-180204; FR 180204; FR180204. |
Protocol | In Vitro | In AP-1-transfected cells, FR180204 dose-dependently inhibits AP-1 transactivation with IC50 of 3.1 μM. |
---|---|---|
In Vivo | FR180204 (100 mg/kg, i.p., b.i.d.) significantly decreases the severity of symptoms and body weight loss in collagen-induced arthritis mice. |
Solvent volume to be added | Mass (the weight of a compound) | |||
---|---|---|---|---|
Mother liquor concentration | 1mg | 5mg | 10mg | 20mg |
1mM | 3.0549 mL | 15.2746 mL | 30.5493 mL | 61.0986 mL |
5mM | 0.6110 mL | 3.0549 mL | 6.1099 mL | 12.2197 mL |
10mM | 0.3055 mL | 1.5275 mL | 3.0549 mL | 6.1099 mL |
20mM | 0.1527 mL | 0.7637 mL | 1.5275 mL | 3.0549 mL |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.